A successive in vitro study concluded that FOXM1 directly binds to the ABCG2 promoter to regulate its transcription, suggesting that lowering FOXM1 expression in NMIBC patients may offer an effective response to chemotherapy and reduce the chance of BC recurrence [95]. The gene discussed is FOXM1; the disease is breast cancer.